scispace - formally typeset
Y

Younan Xia

Researcher at The Wallace H. Coulter Department of Biomedical Engineering

Publications -  974
Citations -  192658

Younan Xia is an academic researcher from The Wallace H. Coulter Department of Biomedical Engineering. The author has contributed to research in topics: Nanocages & Catalysis. The author has an hindex of 216, co-authored 943 publications receiving 175757 citations. Previous affiliations of Younan Xia include Washington University in St. Louis & University of Texas at Dallas.

Papers
More filters
Journal ArticleDOI

Photocatalytic deposition of gold nanoparticles on electrospun nanofibers of titania

TL;DR: In this article, gold nanoparticles, fractal nanosheets or nanowires are selectively deposited on electrospun titania nanofibers through photocatalytic reduction of HAuCl4 in the presence of an organic capping reagent.
Journal ArticleDOI

Self-assembly of spherical colloids into helical chains with well-controlled handedness.

TL;DR: The processing of an achiral material into helical mesostructures having well-controlled handedness should allow us to explore new properties that this material otherwise does not exhibit and may provide valuable insights to improve understanding on the mechanism(s) by which pure enantiomers with a particular sense of rotation evolved in nature.
Journal ArticleDOI

A Sinter-Resistant Catalytic System Based on Platinum Nanoparticles Supported on TiO2 Nanofibers and Covered by Porous Silica

TL;DR: This work demonstrates a thermally stable catalytic system consisting of Pt nanoparticles that are supported on a TiO2 nanofiber and coated with a porous SiO2 sheath that offers an energy barrier to prevent the migration of individual Pt atoms or nanoparticles because of its weak interaction with late transition metals.
Journal ArticleDOI

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

TL;DR: In this article, the authors proposed the use of nanoparticles as a platform for cancer therapy and many other biomedical applications, and demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real-time readout on the treatment efficacy.